Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new sentence is added to Publications indicating publications are provided voluntarily by the submitter, and the descriptor changes from 'about the study results' to 'about the results of the study'; the revision tag updates to v3.3.2 (replacing v3.2.0).SummaryDifference0.3%

- Check19 days agoChange DetectedThe page's notice about government funding status was removed; no study content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedNo significant changes detected on the Study Details page; the study overview, design, eligibility criteria, outcomes, and locations remain unchanged.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page has updated time/status information and removed older status labels; latest dates and counts are now reflected.SummaryDifference0.3%

- Check62 days agoChange DetectedMajor update: added government-operating status notice and links; version bumped from v3.1.0 to v3.2.0 indicating a new release.SummaryDifference1.0%

- Check69 days agoChange DetectedContent expansion and revision: adding new topics (Economics, Health Care Economics and Organizations, Taxes) and updating the version to v3.1.0, while removing older topics (Albumins, Proteins, Albumin-Bound Paclitaxel) and the older version v3.0.2.SummaryDifference0.2%

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.